HIV-1 assembly and release
HIV-1 assembly and release
批准号:
9382562
负责人:
Paul D. Bieniasz
金额:
$21.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-01 至 2017-07-19
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The assembly and release of HIV-1 particles is quite complex, in that a number of viral and cellular RNAs and proteins participate, and while much has been learned about this process, much remains to be discovered. The Gag protein is central to the assembly and release of HIV-1 and all other retrovirus particles. A key function of the Gag protein that will be one focus of tis proposal is the recruitment and packaging of viral genomic RNA (gRNA). Reciprocally, gRNA may help to drive the recruitment of additional Gag molecules into a virion as assembly progresses. However, the full extent to which RNA participates in particle assembly in cells, and how Gag:RNA interactions change as assembly is initiated and completed remain to be defined. The experiments proposed in specific aim 1 will be the first to determine precisely how HIV-1 Gag and gRNA interact in cells. These studies could identify the very first as well as subsequent interactions between Gag protein and gRNA as well as between gRNA and antiviral cytidine deaminases. Following assembly, HIV-1 particles depart from the surface of the infected cell, to colonize neighboring or distal uninfected cells. During the previous funding period, we identified an IFN-induced membrane protein, termed tetherin, as a host defense molecule that inhibits HIV-1 particle release. Our work has demonstrated that tetherin acts directly, to retain nascent virions on the cell surface, but key mechanistic details of how tetherin functions, and what role t plays in preventing the dissemination of viral infection in cultured cells and in vivo remain to b determined. In specific aim 2, we will perform a series of in vitro and in vivo experiments to address these key questions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Broad neutralization of pandemic threat coronaviruses
-
批准号:10327989
-
项目类别:
-
资助金额:$642.33万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Effects of Interferon on primate lentiviruses
-
批准号:10619797
-
项目类别:
-
资助金额:$71.01万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Broad neutralization of pandemic threat coronaviruses
-
批准号:10841237
-
项目类别:
-
资助金额:$425.9万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Effects of Interferon on primate lentiviruses
-
批准号:10708965
-
项目类别:
-
资助金额:$70.56万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Coronavirus neutralizing antibody epitopes and immunogens
-
批准号:10327993
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Coronavirus neutralizing antibody epitopes and immunogens
-
批准号:10841241
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Paul D. Bieniasz
-
依托单位:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
-
批准号:10265576
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
-
批准号:10681282
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
-
批准号:10468987
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
-
批准号:10594493
-
项目类别:
-
资助金额:$135.17万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
-
批准号:10359682
-
项目类别:
-
资助金额:$135.51万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
-
批准号:10160450
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
-
批准号:10037560
-
项目类别:
-
资助金额:$145.19万
-
财政年份:2020
-
负责人:Paul D. Bieniasz
-
依托单位:
Discovery and Mechanism of Antiretroviral Factors
-
批准号:9380381
-
项目类别:
-
资助金额:$50.6万
-
财政年份:2017
-
负责人:Paul D. Bieniasz
-
依托单位:
Discovery and Mechanism of Antiretroviral Factors
-
批准号:8882713
-
项目类别:
-
资助金额:$58.21万
-
财政年份:2016
-
负责人:Paul D. Bieniasz
-
依托单位:
Project 5 - HIV-1 Genome Stability & Editing Mediated by Host
-
批准号:10406229
-
项目类别:
-
资助金额:$58.91万
-
财政年份:2012
-
负责人:Paul D. Bieniasz
-
依托单位:
Project 4 - RNA interactions during HIV-1 assembly and maturation
-
批准号:10245117
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2012
-
负责人:Paul D. Bieniasz
-
依托单位:
The Center for HIV RNA Studies (CRNA)
-
批准号:8512872
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2012
-
负责人:Paul D. Bieniasz
-
依托单位:
Core 5 - Virology, Cell, Molecular & Chemical Biology Core
-
批准号:10245113
-
项目类别:
-
资助金额:$89.23万
-
财政年份:2012
-
负责人:Paul D. Bieniasz
-
依托单位:
Discovery and Mechanism of Antiretroviral Factors
-
批准号:8164400
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2005
-
负责人:Paul D. Bieniasz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ENKD1在纺锤体定向中的作用及分子机制
-
批准号:32000490
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:孙爽
-
依托单位:
果蝇纤毛细胞中特化细胞骨架的结构及其建立的分子基础解析
-
批准号:32070704
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:梁鑫
-
依托单位:
植物基因重组频率的遗传调控
-
批准号:31930018
-
项目类别:重点项目
-
资助金额:300.0万元
-
批准年份:2019
-
负责人:程祝宽
-
依托单位:
肌球蛋白18B通过影响微丝应力纤维组装调控肿瘤细胞迁移的机制研究
-
批准号:31970660
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:酒亚明
-
依托单位:
晶态桥联聚倍半硅氧烷的自导向组装(self-directed assembly)及其发光性能
-
批准号:21171046
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:李焕荣
-
依托单位:
嵌段共聚物多级自组装的多尺度模拟
-
批准号:20974040
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:吕中元
-
依托单位:
"锁住"的金属中心手性-手性笼络合物的动态CD光谱研究与应用开发
-
批准号:20973136
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2009
-
负责人:章慧
-
依托单位:
功能有机配体新颖设计与有机金属超分子导向组装
-
批准号:20772152
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:于澍燕
-
依托单位: